期刊文献+

中美药品监管信息公开制度比较 被引量:5

Comparative Analysis Between SFDA and FDA of Drug Administration Information Disclosure System
暂未订购
导出
摘要 通过对我国SFDA和美国FDA信息公开制度及实施情况进行比较分析,找出SFDA及各地药监局开展信息公开工作时存在问题,探讨我国药品监管信息公开制度如何有效实施。 Through studying the differences between SFDA and FDA of the drug administration information disclosure system and their implementation status,this thesis has analyzed the current problems existing in SFDA and local Food and Drug Administration and explored how should the China's drug administration information disclosure system work.
出处 《中国执业药师》 CAS 2010年第5期38-41,共4页 China Licensed Pharmacist
关键词 SFDA FDA 信息公开 比较分析 SFDA FDA Information Disclosure Comparative Analysis
  • 相关文献

参考文献4

二级参考文献4

  • 1FDA-CDER:Improving Public Health Through Human Drugs CDER Report to the Nation:2005[EB/OL].[ 2006-09-26 ]http://www.fda.gov/cder/reports/rtn/2005/rtn2005.htm
  • 2FDA:The Freedom of Information Act,FOIA basics[EB/OL].[2006-09-26] http://www.gwu.edu/naarchiv/nsa/foia/guide.ht mL
  • 3IOM:preventing medication errors[EB/OL].[2006-09-26 ] http://www.iom.edu/object.file/master/35/943/medication errors new.pdf
  • 4CDER:Natural Disaster Response,[EB/OL].[2006-09-26]http://www.fda.gov/cder/emergency/water-refrig.htm

共引文献7

同被引文献35

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部